Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 170.90
-1.89 (-1.09%)
Jun 1, 2026, 3:29 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 229.44 billion as of June 1, 2026. Its market cap has decreased by -16.70% in one year.
Market Cap
229.44B
Enterprise Value
272.63B
Revenue
88.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
170.90
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 229.44B, an increase of 1.19%. That is a compound annual growth rate of 0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 229.44B | 0.34% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 386.75B |
| Gland Pharma | 370.70B |
| Ajanta Pharma | 365.78B |
| Wockhardt | 330.09B |
| Emcure Pharmaceuticals | 321.54B |
| Eris Lifesciences | 193.86B |
| NATCO Pharma | 181.96B |
| Cohance Lifesciences | 165.08B |